(R)-pantothenic acid multiple interactions ISO RGD:10933 6480464 Pantothenic Acid inhibits the reaction [Valproic Acid results in decreased expression of MYB protein] CTD PMID:16112698 1,2-dimethylhydrazine multiple interactions ISO RGD:10933 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of MYB mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:10933 6480464 1, 2-Dimethylhydrazine results in decreased expression of MYB mRNA CTD PMID:22206623 1,4-benzoquinone increases activity ISO RGD:1349179 6480464 quinone results in increased activity of MYB protein CTD PMID:18778717 1,4-benzoquinone multiple interactions ISO RGD:1349179 6480464 MYB protein promotes the reaction [quinone results in increased expression of TOP2A mRNA] CTD PMID:18778717 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:1349179 6480464 Dinitrochlorobenzene results in decreased expression of MYB mRNA CTD PMID:17374397 17alpha-ethynylestradiol affects expression ISO RGD:10933 6480464 Ethinyl Estradiol affects the expression of MYB mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:10933 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYB mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:10933 6480464 Ethinyl Estradiol results in increased expression of MYB mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1349179 6480464 Estradiol results in increased expression of MYB mRNA CTD PMID:15223131 more ... 17beta-estradiol increases expression ISO RGD:10933 6480464 Estradiol results in increased expression of MYB mRNA CTD PMID:15289156 17beta-estradiol multiple interactions ISO RGD:1349179 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of MYB mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol affects expression ISO RGD:1349179 6480464 Estradiol affects the expression of MYB mRNA CTD PMID:21826169 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10933 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYB mRNA CTD PMID:16102516 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYB mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10933 6480464 Tetrachlorodibenzodioxin affects the expression of MYB mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1349179 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYB mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10933 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MYB mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1349179 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MYB mRNA CTD PMID:19619570 2-butoxyethanol decreases expression ISO RGD:10933 6480464 n-butoxyethanol results in decreased expression of MYB mRNA CTD PMID:19812364 3,3'-diindolylmethane decreases expression ISO RGD:10933 6480464 3, 3'-diindolylmethane analog results in decreased expression of MYB mRNA CTD PMID:26593444 4,4'-sulfonyldiphenol increases expression ISO RGD:1349179 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MYB mRNA CTD PMID:28591870 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:1349179 6480464 Oxazolone results in decreased expression of MYB mRNA CTD PMID:17374397 5-fluorouracil decreases expression ISO RGD:1349179 6480464 Fluorouracil results in decreased expression of MYB mRNA CTD PMID:16557594 5-fluorouracil affects response to substance ISO RGD:10933 6480464 MYB protein affects the susceptibility to Fluorouracil CTD PMID:15235111 5-fluorouracil affects response to substance ISO RGD:1349179 6480464 MYB protein affects the susceptibility to Fluorouracil CTD PMID:15548681 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:36863560 8-Br-cAMP decreases expression ISO RGD:1349179 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYB mRNA CTD PMID:22079614 afimoxifene multiple interactions ISO RGD:1349179 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of MYB mRNA] CTD PMID:21233418 aflatoxin B1 increases expression ISO RGD:1349179 6480464 Aflatoxin B1 results in increased expression of MYB mRNA CTD PMID:22100608 , PMID:32234424 all-trans-retinoic acid decreases expression ISO RGD:1349179 6480464 Tretinoin results in decreased expression of MYB mRNA CTD PMID:12875902 more ... all-trans-retinoic acid decreases expression ISO RGD:10933 6480464 Tretinoin results in decreased expression of MYB mRNA CTD PMID:16604517 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of MYB mRNA CTD PMID:30779732 Apafant decreases expression ISO RGD:10933 6480464 WEB 2086 results in decreased expression of MYB mRNA CTD PMID:11923217 aristolochic acid A decreases expression ISO RGD:1349179 6480464 aristolochic acid I results in decreased expression of MYB mRNA CTD PMID:33212167 atrazine decreases expression ISO RGD:1349179 6480464 Atrazine results in decreased expression of MYB mRNA CTD PMID:22378314 atrazine increases expression ISO RGD:1349179 6480464 Atrazine results in increased expression of MYB mRNA CTD PMID:18585445 benzene increases expression ISO RGD:10933 6480464 Benzene results in increased expression of MYB protein CTD PMID:18281070 , PMID:19913523 benzene decreases expression ISO RGD:1349179 6480464 Benzene results in decreased expression of MYB mRNA CTD PMID:21382456 benzene multiple interactions ISO RGD:10933 6480464 catalase-polyethylene glycol inhibits the reaction [Benzene results in increased expression of MYB protein] CTD PMID:18281070 benzo[a]pyrene decreases expression ISO RGD:10933 6480464 Benzo(a)pyrene results in decreased expression of MYB mRNA CTD PMID:21569818 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of MYB mRNA CTD PMID:34283317 benzo[a]pyrene increases expression ISO RGD:1349179 6480464 Benzo(a)pyrene results in increased expression of MYB mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1349179 6480464 Benzo(a)pyrene results in increased methylation of MYB 3' UTR CTD PMID:27901495 benzophenanthridine decreases expression ISO RGD:1349179 6480464 Benzophenanthridines analog results in decreased expression of MYB mRNA CTD PMID:23117580 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1349179 6480464 Diethylhexyl Phthalate results in decreased expression of MYB mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1349179 6480464 bisphenol A affects the expression of MYB mRNA CTD PMID:21826169 bisphenol A multiple interactions ISO RGD:1349179 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MYB gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MYB mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1349179 6480464 bisphenol A results in increased expression of MYB mRNA CTD PMID:15223131 more ... Bisphenol B increases expression ISO RGD:1349179 6480464 bisphenol B results in increased expression of MYB mRNA CTD PMID:28591870 bisphenol F increases expression ISO RGD:1349179 6480464 bisphenol F results in increased expression of MYB mRNA CTD PMID:28591870 bisphenol F increases expression ISO RGD:10933 6480464 bisphenol F results in increased expression of MYB mRNA CTD PMID:30951980 calcitriol decreases expression ISO RGD:1349179 6480464 Calcitriol results in decreased expression of MYB mRNA CTD PMID:12875902 more ... calcitriol multiple interactions ISO RGD:1349179 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of MYB mRNA CTD PMID:21592394 calyculin a increases expression ISO RGD:10933 6480464 calyculin A results in increased expression of MYB mRNA CTD PMID:25270620 capecitabine increases response to substance ISO RGD:1349179 6480464 MYB protein results in increased susceptibility to Capecitabine CTD PMID:16734730 carbon nanotube decreases expression ISO RGD:10933 6480464 Nanotubes more ... CTD PMID:25554681 catechol multiple interactions ISO RGD:10933 6480464 AHR gene mutant form inhibits the reaction [catechol results in decreased expression of MYB protein] CTD PMID:15935814 catechol decreases expression ISO RGD:10933 6480464 catechol results in decreased expression of MYB protein CTD PMID:15935814 chlordecone multiple interactions ISO RGD:10933 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to MYB gene] CTD PMID:31084621 chlorpyrifos decreases expression ISO RGD:10933 6480464 Chlorpyrifos results in decreased expression of MYB mRNA CTD PMID:32715474 ciprofibrate decreases expression ISO RGD:1349179 6480464 ciprofibrate results in decreased expression of MYB mRNA, ciprofibrate results in decreased expression of MYB protein CTD PMID:12649303 clofibrate decreases expression ISO RGD:1349179 6480464 Clofibrate results in decreased expression of MYB mRNA, Clofibrate results in decreased expression of MYB protein CTD PMID:12649303 clomiphene decreases expression ISO RGD:1349179 6480464 Clomiphene results in decreased expression of MYB mRNA CTD PMID:26865669 cobalt dichloride decreases expression ISO RGD:1349179 6480464 cobaltous chloride results in decreased expression of MYB mRNA CTD PMID:22941251 copper atom multiple interactions ISO RGD:1349179 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MYB mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1349179 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MYB mRNA CTD PMID:20971185 coumestrol multiple interactions ISO RGD:1349179 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 coumestrol increases expression ISO RGD:1349179 6480464 Coumestrol results in increased expression of MYB mRNA CTD PMID:19167446 dexamethasone increases expression ISO RGD:1349179 6480464 Dexamethasone results in increased expression of MYB mRNA CTD PMID:16144937 diethylstilbestrol increases expression ISO RGD:1349179 6480464 Diethylstilbestrol results in increased expression of MYB mRNA CTD PMID:26865669 diethylstilbestrol increases expression ISO RGD:10933 6480464 Diethylstilbestrol results in increased expression of MYB mRNA CTD PMID:15289156 dioxygen decreases expression ISO RGD:1349179 6480464 Oxygen deficiency results in decreased expression of MYB mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:10933 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYB mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1349179 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxifluridine increases response to substance ISO RGD:1349179 6480464 MYB protein results in increased susceptibility to doxifluridine CTD PMID:16734730 Enterolactone multiple interactions ISO RGD:1349179 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYB mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:1349179 6480464 entinostat results in decreased expression of MYB mRNA CTD PMID:27188386 estrone increases expression ISO RGD:1349179 6480464 Estrone results in increased expression of MYB mRNA CTD PMID:26865669 eugenol decreases expression ISO RGD:1349179 6480464 Eugenol results in decreased expression of MYB mRNA CTD PMID:17374397 folic acid multiple interactions ISO RGD:10933 6480464 Folic Acid inhibits the reaction [1 more ... CTD PMID:16112698 , PMID:22206623 fulvestrant decreases expression ISO RGD:1349179 6480464 fulvestrant results in decreased expression of MYB mRNA CTD PMID:26865669 fulvestrant multiple interactions ISO RGD:1349179 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MYB gene CTD PMID:31601247 gemcitabine increases expression ISO RGD:1349179 6480464 Gemcitabine results in increased expression of MYB mRNA CTD PMID:17039268 genistein increases expression ISO RGD:1349179 6480464 Genistein results in increased expression of MYB mRNA CTD PMID:16474171 , PMID:26865669 genistein increases expression ISO RGD:10933 6480464 Genistein results in increased expression of MYB mRNA CTD PMID:15289156 geraniol decreases expression ISO RGD:1349179 6480464 geraniol results in decreased expression of MYB mRNA CTD PMID:27683099 glyphosate decreases expression ISO RGD:1349179 6480464 glyphosate results in decreased expression of MYB mRNA CTD PMID:28711546 , PMID:31295307 glyphosate increases expression ISO RGD:1349179 6480464 glyphosate results in increased expression of MYB mRNA CTD PMID:28711546 hexestrol increases expression ISO RGD:1349179 6480464 Hexestrol results in increased expression of MYB mRNA CTD PMID:26865669 hydrogen peroxide affects expression ISO RGD:1349179 6480464 Hydrogen Peroxide affects the expression of MYB mRNA CTD PMID:20044591 hydroquinone decreases expression ISO RGD:1349179 6480464 hydroquinone results in decreased expression of MYB mRNA CTD PMID:22245671 hydroxyurea decreases expression ISO RGD:10933 6480464 Hydroxyurea results in decreased expression of MYB mRNA CTD PMID:12929121 irinotecan increases response to substance ISO RGD:1349179 6480464 MYB protein results in increased susceptibility to Irinotecan CTD PMID:16734730 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of MYB protein CTD PMID:7593635 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of MYB protein CTD PMID:7593635 leflunomide decreases expression ISO RGD:10933 6480464 leflunomide results in decreased expression of MYB mRNA CTD PMID:19751817 lipopolysaccharide increases expression ISO RGD:1349179 6480464 Lipopolysaccharides results in increased expression of MYB mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1349179 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MYB mRNA CTD PMID:35811015 malonaldehyde increases expression EXP 6480464 Malondialdehyde results in increased expression of MYB protein CTD PMID:7593635 medroxyprogesterone acetate decreases expression ISO RGD:1349179 6480464 Medroxyprogesterone Acetate results in decreased expression of MYB mRNA CTD PMID:18497975 mestranol increases expression ISO RGD:1349179 6480464 Mestranol results in increased expression of MYB mRNA CTD PMID:26865669 methotrexate increases expression ISO RGD:1349179 6480464 Methotrexate results in increased expression of MYB mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO RGD:1349179 6480464 Methyl Methanesulfonate results in decreased expression of MYB mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1349179 6480464 methylmercuric chloride results in increased expression of MYB mRNA CTD PMID:23179753 , PMID:27188386 N-(6-acetamidohexyl)acetamide decreases expression ISO RGD:1349179 6480464 hexamethylene bisacetamide results in decreased expression of MYB protein CTD PMID:10597302 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:10933 6480464 Ethylnitrosourea results in increased mutagenesis of MYB gene CTD PMID:16724327 ozone multiple interactions ISO RGD:10933 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MYB mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MYB mRNA CTD PMID:34911549 p-anisidine decreases expression ISO RGD:10933 6480464 4-anisidine results in decreased expression of MYB mRNA CTD PMID:12929121 p-menthan-3-ol decreases expression ISO RGD:1349179 6480464 Menthol results in decreased expression of MYB mRNA CTD PMID:26760959 phenylmercury acetate decreases expression ISO RGD:1349179 6480464 Phenylmercuric Acetate results in decreased expression of MYB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349179 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYB mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:10933 6480464 pirinixic acid results in decreased expression of MYB mRNA CTD PMID:17426115 progesterone decreases expression ISO RGD:10933 6480464 Progesterone results in decreased expression of MYB mRNA CTD PMID:16966611 , PMID:22238285 progesterone decreases expression ISO RGD:1349179 6480464 Progesterone results in decreased expression of MYB mRNA CTD PMID:18497975 quercetin decreases expression ISO RGD:1349179 6480464 Quercetin results in decreased expression of MYB mRNA CTD PMID:14715546 raloxifene decreases expression ISO RGD:1349179 6480464 Raloxifene Hydrochloride results in decreased expression of MYB mRNA CTD PMID:26865669 raloxifene multiple interactions ISO RGD:1349179 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in increased expression of MYB mRNA] CTD PMID:21185374 rotenone decreases expression ISO RGD:1349179 6480464 Rotenone results in decreased expression of MYB mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1349179 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MYB mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1349179 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1349179 6480464 Silicon Dioxide analog results in decreased expression of MYB mRNA CTD PMID:23806026 silver atom decreases expression ISO RGD:10933 6480464 Silver results in decreased expression of MYB mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:10933 6480464 Silver results in decreased expression of MYB mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:1349179 6480464 sodium arsenite results in increased expression of MYB mRNA CTD PMID:34032870 styrene affects expression ISO RGD:10933 6480464 Styrene affects the expression of MYB mRNA CTD PMID:28951217 succimer multiple interactions ISO RGD:1349179 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYB mRNA CTD PMID:26378955 sulforaphane increases expression ISO RGD:10933 6480464 sulforaphane results in increased expression of MYB mRNA CTD PMID:30529165 sulforaphane decreases expression ISO RGD:1349179 6480464 sulforaphane results in decreased expression of MYB mRNA CTD PMID:31838189 tamibarotene affects expression ISO RGD:1349179 6480464 tamibarotene affects the expression of MYB mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:10933 6480464 Tamoxifen affects the expression of MYB mRNA CTD PMID:17555576 temozolomide increases expression ISO RGD:1349179 6480464 Temozolomide results in increased expression of MYB mRNA CTD PMID:31758290 testosterone multiple interactions ISO RGD:1349179 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of MYB mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1349179 6480464 Testosterone results in decreased expression of MYB mRNA CTD PMID:21592394 thalidomide decreases activity ISO RGD:1349179 6480464 Thalidomide results in decreased activity of MYB protein CTD PMID:16616857 thalidomide multiple interactions ISO RGD:1349179 6480464 CAT protein inhibits the reaction [Thalidomide results in decreased activity of MYB protein] CTD PMID:16616857 thalidomide decreases phosphorylation ISO RGD:1349179 6480464 Thalidomide results in decreased phosphorylation of MYB protein CTD PMID:16616857 thapsigargin decreases expression ISO RGD:1349179 6480464 Thapsigargin results in decreased expression of MYB mRNA CTD PMID:22378314 thifluzamide decreases expression ISO RGD:1349179 6480464 thifluzamide results in decreased expression of MYB mRNA CTD PMID:33512557 titanium dioxide affects expression ISO RGD:10933 6480464 titanium dioxide affects the expression of MYB mRNA CTD PMID:23557971 titanium dioxide increases expression ISO RGD:10933 6480464 titanium dioxide results in increased expression of MYB mRNA CTD PMID:29264374 Tributyltin oxide increases expression ISO RGD:10933 6480464 bis(tri-n-butyltin)oxide results in increased expression of MYB mRNA CTD PMID:18958704 trichostatin A decreases expression ISO RGD:1349179 6480464 trichostatin A results in decreased expression of MYB mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO RGD:10933 6480464 trimellitic anhydride results in increased expression of MYB mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1349179 6480464 troglitazone results in decreased expression of MYB mRNA, troglitazone results in decreased expression of MYB protein CTD PMID:12649303 troglitazone decreases expression ISO RGD:10933 6480464 troglitazone results in decreased expression of MYB mRNA CTD PMID:17569031 tunicamycin decreases expression ISO RGD:1349179 6480464 Tunicamycin results in decreased expression of MYB mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:1349179 6480464 Valproic Acid affects the expression of MYB mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1349179 6480464 Valproic Acid results in decreased expression of MYB mRNA CTD PMID:23179753 , PMID:28001369 valproic acid multiple interactions ISO RGD:10933 6480464 Folic Acid inhibits the reaction [Valproic Acid results in decreased expression of MYB protein], Pantothenic Acid inhibits the reaction [Valproic Acid results in decreased expression of MYB protein] CTD PMID:16112698 valproic acid decreases expression ISO RGD:10933 6480464 Valproic Acid results in decreased expression of MYB protein CTD PMID:16112698 vorinostat multiple interactions ISO RGD:1349179 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYB mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:1349179 6480464 vorinostat results in decreased expression of MYB protein CTD PMID:10597302 WR-1065 increases expression ISO RGD:1349179 6480464 N-(2-mercaptoethyl)-1, 3-diaminopropane results in increased expression of MYB mRNA CTD PMID:12007958 zinc atom increases activity ISO RGD:1349179 6480464 Zinc deficiency results in increased activity of MYB protein CTD PMID:18356318 zinc(0) increases activity ISO RGD:1349179 6480464 Zinc deficiency results in increased activity of MYB protein CTD PMID:18356318